2017
Urban Health Systems: Overview
Ompad D, Galea S, Vlahov D. Urban Health Systems: Overview. 2017, 311-317. DOI: 10.1016/b978-0-12-803678-5.00481-1.Peer-Reviewed Original Research
2008
Urban Health Systems: Overview
Ompad D, Galea S, Vlahov D. Urban Health Systems: Overview. 2008, 463-470. DOI: 10.1016/b978-012373960-5.00323-3.Chapters
2006
The Nonimpact of the Expanded Syringe Access Program upon Heroin Use, Injection Behaviours, and Crime Indicators in New York City and State
Johnson B, Golub A, Deren S, Jarlais D, Fuller C, Vlahov D. The Nonimpact of the Expanded Syringe Access Program upon Heroin Use, Injection Behaviours, and Crime Indicators in New York City and State. Justice Research And Policy 2006, 8: 27-49. DOI: 10.3818/jrp.8.1.2006.27.Peer-Reviewed Original ResearchSyringe access programsHeroin useDrug usersAccess programInjection drug usersBlood-borne diseasesHealth care providersIllicit drug usersExpanded Syringe Access ProgramHepatitis C.Drug injectionDrug treatmentCare providersClean syringesSyringe accessSubstance abuseNew York StateLarger evaluationSyringesInjection behaviorNew York CityHIVYork CityDisease
2001
Multiple Access to Sterile Syringes for Injection Drug Users: Vending Machines, Needle Exchange Programs and Legal Pharmacy Sales in Marseille, France
Moatti J, Vlahov D, Feroni I, Perrin V, Obadia Y. Multiple Access to Sterile Syringes for Injection Drug Users: Vending Machines, Needle Exchange Programs and Legal Pharmacy Sales in Marseille, France. European Addiction Research 2001, 7: 40-45. PMID: 11316925, DOI: 10.1159/000050713.Peer-Reviewed Original ResearchConceptsInjection drug usersNeedle exchange programsSterile syringesNEP usersNew syringesPharmacy salesCharacteristics of IDUsDrug usersPrevention of HIVDrug use characteristicsHIV prevention programsSelf-administered questionnaireMethadone programsHeroin injectorsUseful adjunctPrevention programsInfectious diseasesProgram utilizationHIVSyringesPharmacyExchange programsQuestionnaireBuprenorphineDisease
1995
Human Immunodeficiency Virus Type 1 env and p17gag Sequence Variation in Polymerase Chain Reaction-Positive, Seronegative Injection Drug Users
Markham R, Yu X, Farzadegan H, Ray S, Vlahov D. Human Immunodeficiency Virus Type 1 env and p17gag Sequence Variation in Polymerase Chain Reaction-Positive, Seronegative Injection Drug Users. The Journal Of Infectious Diseases 1995, 171: 797-804. PMID: 7706805, DOI: 10.1093/infdis/171.4.797.Peer-Reviewed Original ResearchMeSH KeywordsAmino Acid SequenceBase SequenceCross-Sectional StudiesDNA, ViralFemaleGag Gene Products, Human Immunodeficiency VirusGene Products, envGene Products, gagGenes, envGenes, gagGenetic VariationHIV AntigensHIV InfectionsHIV-1HumansMaleMolecular Sequence DataPhylogenyPolymerase Chain ReactionSequence AlignmentSequence Analysis, DNASubstance Abuse, IntravenousViral ProteinsConceptsSeronegative injection drug usersInjection drug usersDrug usersHuman Immunodeficiency Virus Type 1 EnvCross-sectional studyPolymerase chainHIV-1 genesThird hypervariable regionAbility of virusesV3 loopMucosal surfacesIntersubject variationEnvelope regionInfected cellsAmino acid variationsEnvP17gagSeminal fluidVirusAcid variationsHypervariable regionInfectionDiseaseGeographic Variation in HIV Infection among Injecting Drug Users within Barcelona
Roca J, Vlahov D, Borrell C, Jansa J, Brugal T, Yazbeck H, Muñoz A. Geographic Variation in HIV Infection among Injecting Drug Users within Barcelona. Substance Use & Misuse 1995, 30: 219-229. PMID: 7759174, DOI: 10.3109/10826089509060744.Peer-Reviewed Original Research
1994
Epidemiology of Hepatitis B Virus Infections among Injecting Drug Users: Seroprevalence, Risk Factors, and Viral Interactions
Levine O, Vlahov D, Nelson K. Epidemiology of Hepatitis B Virus Infections among Injecting Drug Users: Seroprevalence, Risk Factors, and Viral Interactions. Epidemiologic Reviews 1994, 16: 418-436. PMID: 7713187, DOI: 10.1093/oxfordjournals.epirev.a036161.Peer-Reviewed Original Research